Category Added in a WPeMatico Campaign
Buyer Consortium at one point offered All-Cash Proposal of US$29.50 Per Share to acquire Hollysys Buyer Consortium remains committed to...
Award ceremony takes place in Tokyo on April 16th TOKYO--(BUSINESS WIRE)--The Japan Prize Foundation announced the winners of the 2024...
New Indication Delivers on Takeda’s Commitment to Expanding its Broad and Diverse Immunoglobulin (IG) Portfolio to Meet the Needs of...
DUBLIN--(BUSINESS WIRE)--The "The Philippines Construction Market Size, Trends, and Forecasts by Sector - Commercial, Industrial, Infrastructure, Energy and Utilities, Institutional...
LOS ANGELES & BENGALURU, India--(BUSINESS WIRE)--Pixxel, a leader in innovative hyperspectral earth-imaging technology, today announced the appointment of William McCombe...
Higlobe is the first service to offer a lowest cost guarantee for international payments Higlobe will match the price of...
DUBLIN--(BUSINESS WIRE)--The "Singapore Ecommerce Market Opportunities Databook - 100+ KPIs on Ecommerce Verticals (Shopping, Travel, Food Service, Media & Entertainment,...
NEW YORK--(BUSINESS WIRE)--Rapyuta Robotics, Co., Ltd., the leading provider of collaborative pick-assist autonomous mobile robots (Rapyuta PA-AMR) in Japan with...
THE WOODLANDS, Texas--(BUSINESS WIRE)--Excelerate Energy, Inc. (NYSE: EE) (the Company or Excelerate) and QatarEnergy announced today the execution of a...
LAHORE, Pakistan--(BUSINESS WIRE)--#blockchain--KuCoin, a global top 5 cryptocurrency exchange, took center stage at the Future Fest to discuss the burgeoning...
With an Aim to Revolutionize the Liquor Circulation Industry in China since 2001, Jiuxian has been Ranking First in the...
TOKYO--(BUSINESS WIRE)--We hereby announce today that the attached press release issued by Bloom 1 K.K. titled “Notice Regarding Commencement of...
Aria Holding to invest over INR 2,000 crore to establish a state-of-the-art float glass plant in Maharashtra to bolster infrastructure...
HYQVIA becomes the Only Facilitated Subcutaneous Immunoglobulin, Offering Patients an up to Once-Monthly Treatment Option At-Home or In-Office Administration Provides...
Application based on results from DESTINY-PanTumor02 trial and supported by additional ENHERTU data Submission to be reviewed under FDA Real...
